FDA: “No Evidence” Second Pfizer COVID Pill Stops Repeat Symptoms, Contradicting CEO

May 5, 2022

(Axios) – A Food and Drug Administration (FDA) official said Wednesday that there is “no evidence” that a second round of the Pfizer COVID pill Paxlovid will help patients who suffer a relapse in symptoms. Why it matters: The FDA’s comments contradict Pfizer chief executive officer Albert Bourla, who said patients experiencing COVID-19 symptoms after their first treatment can take more of the pill. (Read More)